Creating miracles, one family at a time: Our passion for reproductive medicine and genetics is fueled by your dreams.

We are one of the biggest and fastest-growing assisted reproductive technology providers in the world.

Since the FutureLife group was founded in 2014, we continue to grow each year. Today, we have over 38 clinics across 8 European countries, run by more than 1,000 skilled team members and 450 doctors. Our clinics offer comprehensive sterility treatment, including genetic, immunological, and other follow-up tests. Our main aim is to provide quality care and effective treatments to create healthy babies and happy families. We are continuously investing in our clinics, research, and training. This helps us offer expertise, financial stability, good working conditions, and competitive pay for our teams.

0

Clinics

0+

Specialists

0

Countries

0+

Treatment cycles
What we do ?

Where science meets compassion: Leading the way in reproductive medicine and genetics.

Passion for what we do

Our team of 1500 specialists spread across 38 clinics help individuals and couples to fulfill their dream of becoming parents. Using advanced and innovative techniques in assisted reproduction, we help to create healthy babies and happy families.

Intrauterine insemination (IUI)

Intrauterine insemination involves placing the sperm directly inside the womb around the time when the egg/eggs are released. It can be in a natural cycle around ovulation or in a medicated cycle. It is less invasive than other forms of fertility treatment.

In Vitro Fertilization (IVF)

IVF treatment is a highly effective method for treating fertility issues. Fertility hormones are used to stimulate the ovaries to produce eggs. The eggs are collected through a procedure called egg collection and are then combined with the sperm in the laboratory aiming to create embryos.

Donor
programme

This treatment pathway includes the use of donated eggs or sperm. Donor programs have supported many individuals and couples in creating happy families and healthy babies.

Fertility Preservation

Egg freezing (also called oocyte cryopreservation) is a fertility treatment that gives the opportunity to
women to preserve their fertility by freezing their eggs and storing them for future use. This is an option
for women who for various reasons (personal/social/medical) wish to postpone pregnancy and to
preserve the fertility for the future.

FutureLife Gamete Bank

We provide best-in-class care as Europe's leading assisted reproductive technology provider through our donor egg bank. Our thorough screening, skilled doctors, and caring approach aim to maximize the chances of success. We take many precautions to protect our patients, donors, and professionals, ensuring a safe environment and the highest quality care.

Other services

We also offer a wide range of treatments including fetal medicine, allergy care, immunology, inflammatory bowel disease, plastic surgery, dermatology, diabetes care, endocrinology, gastroenterology, gynecology, cardiology, oncology, neurology, orthopedics, psychiatry, rehabilitation, X-ray and ultrasound services, dentistry, urology and andrology.

Laboratory

Our laboratories specialize in genetics, which includes molecular genetics, cytogenetics, PGT, and bioinformatics, as well as embryology and immunology. The FutureLife group has one of Europe's most advanced genetic laboratories, called GNTlabs by GENNET.
GNTlabs offers various genetic tests, such as screenings to assess disease risks, carrier tests for identifying genetic mutations passed to children, and diagnostic tests to detect genetic disorders. For more information, visit the Gennet website here (www.gennet.cz).

Pharmacy

Serpha is our online pharmacy specializing in fertility medication. For more information, visit the Serpha website here (serpha.eu).

FutureLife
Executive team

Francisco Lobbosco

Chief Executive Officer

Francisco joined the FutureLife team in April 2023. With over 20 years of experience spanning multiple industries and geographies, including roles at AniCura (Veterinary Health - Europe), GrandVision (Optical retail – 43 countries), Nike (Wholesale / Retail – EM...

Read more

Francisco Lobbosco

Chief Executive Officer

Francisco joined the FutureLife team in April 2023. With over 20 years of experience spanning multiple industries and geographies, including roles at AniCura (Veterinary Health - Europe), GrandVision (Optical retail – 43 countries), Nike (Wholesale / Retail – EMEA), and Banking (LATAM), Francisco excels in leading, mentoring, and inspiring teams to address complex business challenges with a focus on rapid improvement. He thrives in a culture characterized by integrity, inspiration, and curiosity. Francisco holds a Master's degree in Economics from the Universidad de Buenos Aires and an MBA from IAE Business School.

Jane Exon

Chief Growth Officer

Jane joined FutureLife in September 2023 as Chief Growth Officer, bringing a wealth of expertise in marketing, pricing strategies, and business development. Jane's held various leadership roles at Debenhams. These roles enabled her to successfully demonstrate h...

Read more

Jane Exon

Chief Growth Officer

Jane joined FutureLife in September 2023 as Chief Growth Officer, bringing a wealth of expertise in marketing, pricing strategies, and business development. Jane's held various leadership roles at Debenhams. These roles enabled her to successfully demonstrate her ability to develop marketing talent, building high-performing teams, and deliver successful marketing campaigns across multiple media platforms. Her contributions have been recognised with many prestigious awards. These included the World Retail Award for Best Social Media Campaign, a Cannes Lion for an innovative digital Mother’s Day campaign, and most recently an award for a campaign which celebrated women’s health in mid-life. Throughout her career, she has shown a remarkable talent for brand positioning and precise consumer targeting. Collaborating closely with clinical leaders and using consumer insights has been a crucial part of her success.

Jaroslava Hirschová

Chief Financial Officer

Jarka joined FutureLife team as Chief Financial Officer in January 2024. Jarka has an extensive experience in financial management, business partnering, strategic planning and implementation with international reach within highly regulated industries. Jarka has ...

Read more

Jaroslava Hirschová

Chief Financial Officer

Jarka joined FutureLife team as Chief Financial Officer in January 2024. Jarka has an extensive experience in financial management, business partnering, strategic planning and implementation with international reach within highly regulated industries. Jarka has served as Chief Financial Officer and a board member in several private equity portfolio as well as publicly listed companies. Until recently, and for almost 9 years, she was the Group CFO, member of the Executive Committee, and board member of the Fortuna Entertainment Group (FEG) where she played a critical role in the company’s step change value creation and business transformation across their 5 CEE markets. Prior to her role in FEG, Jaroslava served as CFO and board member in Prima banka Slovakia for 3,5 years, following CFO roles in CSOB Pojistovna and Ceska pojistovna. She also previously held a number of executive financial leadership roles at GE Capital where she worked for 12 years across the Czech Republic, Slovakia, the UK and Finland.

Jonáš Vokřál

Vice President of Operations for CEE

Jonáš joined FutureLife in 2018, and is currently Vice President of Operations for CEE. Since 2016, he has held the position of Reprofit Clinic Director. His previous experience includes a management role at Repromeda and involvement in healthcare institution ...

Read more

Jonáš Vokřál

Vice President of Operations for CEE

Jonáš joined FutureLife in 2018, and is currently Vice President of Operations for CEE. Since 2016, he has held the position of Reprofit Clinic Director. His previous experience includes a management role at Repromeda and involvement in healthcare institution audits at Price Waterhouse Coopers. He graduated from the Faculty of Business and Economics at Mendel University in Brno. Following this, he pursued further studies in South Africa and completed an MBA at the University of St. Francis in Chicago.

Štěpán Machač

Chief Medical Officer for CEE

In 2018, Dr. Štěpán Machač, PhD. joined FutureLife as the Chief Medical Officer. Previously, he held significant roles focusing on reproductive medicine. Graduating from Palacký University of Medicine in Olomouc, he also holds a PhD focusing on Inherited Thrombo...

Read more

Štěpán Machač

Chief Medical Officer for CEE

In 2018, Dr. Štěpán Machač, PhD. joined FutureLife as the Chief Medical Officer. Previously, he held significant roles focusing on reproductive medicine. Graduating from Palacký University of Medicine in Olomouc, he also holds a PhD focusing on Inherited Thrombophilia related to severe OHSS. His career started at the Gynaecology and Obstetrics Clinic at Palacký University Olomouc from 1995 to 2003, where he began focusing on infertility treatment. Prior to his role at FutureLife, between 2006 and 2014, Dr. Machač was the lead IVF doctor for international patients at Reprofit International Clinic. Since 2014, he has overseen the IVF Clinic in Olomouc. Additionally, since 2020, Dr. Machač has been the Chairman of Section of Assisted Reproduction at the Czech Medical Society. He is also an author, writing ad co-writing over 30 lectures and 40 professional articles on assisted reproduction, ovarian hyperstimulation syndrome, and gamma donation.

Hans Arce

Chief Medical Officer for WE

Dr. Hans, Chief Medical Officer for WE, is an accomplished specialist with a passion for improving lives, through reproductive healthcare. He studied at Universidad Peruana Cayetano Heredia in Lima, Peru, where he worked with disadvantaged individuals for two ...

Read more

Hans Arce

Chief Medical Officer for WE

Dr. Hans, Chief Medical Officer for WE, is an accomplished specialist with a passion for improving lives, through reproductive healthcare. He studied at Universidad Peruana Cayetano Heredia in Lima, Peru, where he worked with disadvantaged individuals for two years. He then continued his studies in Obstetrics and Gynaecology at Hospital Clinic de Barcelona in Spain. With nine years of experience at a leading fertility clinic in Barcelona, Dr. Hans has assisted infertile couples with medical and surgical treatments to start families. He is committed to providing personalised care and support, ensuring every patient receives the best treatment possible. Dr. Hans is committed to making a positive impact in reproductive medicine and helping individuals and couples achieve their dreams of starting a family.

Ignacio Couto

Chief Transformation Officer

Ignacio joined FutureLife as Chief Transformation Officer in November 2023, bringing over 20 years of extensive experience in innovation and technology across Europe, the Americas, and the Middle East. Previously, as Managing Director at Seidor, Ignacio lead a ...

Read more

Ignacio Couto

Chief Transformation Officer

Ignacio joined FutureLife as Chief Transformation Officer in November 2023, bringing over 20 years of extensive experience in innovation and technology across Europe, the Americas, and the Middle East. Previously, as Managing Director at Seidor, Ignacio lead a comprehensive portfolio of innovation solutions across 39 countries. His leadership roles at NEORIS and CEMEX were instrumental in driving successful global digital transformation initiatives and establishing data-driven operations. His academic background includes a degree in Telecommunications Engineering, an MBA from IESE, and a degree in Philosophy.